Medicare Enrolled

Dr. Darren McGuire, MD

Cardiovascular Disease · Dallas, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
5323 HARRY HINES BLVD, Dallas, TX 75390
2146458000
In practice since 2006 (19 years)
NPI: 1336106715 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McGuire from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McGuire? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McGuire

Dr. Darren McGuire is a cardiovascular disease in Dallas, TX, with 19 years in practice. Based on federal Medicare data, Dr. McGuire performed 136 Medicare services across 102 unique beneficiaries.

Between the years covered by Open Payments, Dr. McGuire received a total of $1,347,980 from 40 pharmaceutical and/or device companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McGuire is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 136 Medicare services$ $1,347,980 industry payments

Medicare Practice Summary

Medicare Utilization ↗
136
Medicare services
Bottom 6% in TX for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
102
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity47$95$336
Office visit, established patient (30-39 min)36$75$344
Initial hospital admission, high complexity16$121$654
EKG interpretation and report14$5$36
Hospital discharge day management, 30 minutes or less12$59$233
Initial hospital admission, moderate complexity11$93$445
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,347,980
Total received (2018-2024)
Avg $192,569/year across 7 years
Top 0% in TX for cardiovascular disease
40
Companies
608
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,067,884 (79.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$140,323 (10.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$139,772 (10.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$162,597
2023
$220,625
2022
$127,164
2021
$97,433
2020
$157,264
2019
$321,302
2018
$261,596

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$174,382
Novo Nordisk AS
$160,039
Boehringer Ingelheim International GmbH
$148,128
Eli Lilly and Company
$146,547
Boehringer Ingelheim b.v.
$76,114
Merck Sharp & Dohme Corporation
$67,947
Boehringer Ingelheim Pty Ltd
$66,108
SANOFI US SERVICES INC.
$60,398
Boehringer Ingelheim Pharmaceuticals, Inc.
$57,876
INTERCEPT PHARMACEUTICALS, INC.
$47,402
SANOFI-AVENTIS U.S. LLC
$45,335
PFIZER INC.
$37,050
CSL Behring
$32,432
AstraZeneca Pharmaceuticals LP
$26,201
Lexicon Pharmaceuticals, Inc.
$24,073
Janssen Research & Development, LLC
$17,250
GlaxoSmithKline, LLC.
$17,069
Sarepta Therapeutics, Inc.
$14,000
Boehringer Ingelheim Mexico SA de CV
$12,000
Otsuka Pharmaceutical Development & Commercialization, Inc.
$11,750
Dynavax Technologies Corporation
$11,750
Alnylam Pharmaceuticals Inc.
$10,928
Ipsen Bioscience Inc
$10,500
Neovasc Medical Inc
$9,100
IDORSIA PHARMACEUTICALS US INC
$8,254
Boehringer Ingelheim Singapore Pte. Ltd.
$8,060
AbbVie Inc.
$7,975
Boehringer Ingelheim MENA (Scientific Office) FZ-LLC
$7,830
Bayer HealthCare Pharmaceuticals Inc.
$7,257
AstraZeneca UK Limited
$6,374
Boehringer Ingelheim (Phil.) Inc.
$4,000
Amgen Inc.
$3,188
Boehringer Ingelheim India Pvt. Ltd.
$2,320
Janssen Scientific Affairs, LLC
$2,000
EISAI INC.
$2,000
ABBVIE INC.
$1,925
AbbVie, Inc.
$1,375
AltaThera Pharmaceuticals LLC
$600
Esperion Therapeutics, Inc.
$319
Medtronic, Inc.
$124
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
BRILINTA · Belviq · EPANOVA · FARXIGA · Heplisav-B · INVOKANA · JANUVIA · JARDIANCE · Kerendia · MICRA · MOUNJARO · NEXLETOL · Non-Covered · Ozempic · RESOLUTE ONYX · Repatha · SHINGRIX · SOLIQUA 100/33 · SOTAGLIFLOZIN · STEGLATRO · Sotalol Hydrochloride · TRADJENTA · Tryvio · Victoza · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for cardiovascular disease in TX.

Equivalent to $991,162 per 100 Medicare services performed
Looking for a cardiovascular disease in Dallas?
Compare cardiovascular diseases in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
304
Per 100K population
11.7
County median income
$74,149
Nearest hospital
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. McGuire is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. McGuire experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. McGuire performed 47 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McGuire receive payments from pharmaceutical companies?
Yes. Dr. McGuire received a total of $1,347,980 from 40 companies across 608 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McGuire's costs compare to other cardiovascular diseases in Dallas?
Dr. McGuire's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McGuire) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →